News & AnalysisTherini Bio nabs $17mSouth San Francisco-based Therini Bio, a vascular biology company, has secured $17 million in funding.ByIris Dorbian10 May 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs